Retatrutide is expected to become commercially available in late 2027 or 2028, pending successful completion of Phase 3 trials and FDA approval
Where suitable, our UK prescribing and pharmacy team will recommend an appropriate option before checkout
How Rectal Bleeding Is Evaluated Evaluation often begins with a medical history and physical examination
Close monitoring is recommended, particularly during the initial weeks or after dose increases, to ensure tolerability and detect potential complications like bile duct stones or pancreatitis
If approved, treatment with Retatrutide may be suitable for: Adults who are Overweight: BMI 27 with related health conditions such as fatty liver disease, type 2 diabetes, sleep apnea, high blood pressure, or high cholesterol
Known as the "master antioxidant," glutathione is essential for protecting cells from oxidative stress and damage c